SYNergy ScienTech Corp. AI Stock Analysis
SYNergy ScienTech Corp. (6558) AI Stock Analysis
SYNergy ScienTech Corp.
(TWSE:6558)
SYNergy ScienTech scores in the lower-mid range, driven primarily by a deteriorating operating business: six straight years of revenue contraction, a widening net loss and near-zero EBITDA margins. This is only partly offset by a genuinely strong balance sheet — minimal debt, ~80% equity funding — and self-funding, depreciation-driven free cash flow that give management time to restructure. Technicals reinforce the caution, with the price below all major moving averages and negative MACD, though the very low RSI and Stochastic readings flag deeply oversold conditions that could spark a short-term bounce. Valuation provides no anchor given negative earnings, with only a modest 1.56% dividend yield offering limited support. The key watch item is whether stabilizing gross margins and cost actions restore operating profitability before the equity cushion thins further.
SYNergy ScienTech Corp. (6558) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 1.79B
- Dividend Yield
- 1.55%
- Average Volume (3M)
- 194.96K
- Price to Earnings (P/E)
- -16.0
- Beta (1Y)
- 0.99
- Revenue Growth
- -10.07%
- EPS Growth
- -349.71%
- Country
- TW
- Employees
- 80
- Sector
- General
- Sector Strength
- 55
- Industry
- Electrical Equipment & Parts
SYNergy ScienTech Corp. Business Overview & Revenue Model
Company Description
SYNergy ScienTech Corp. (6558.TW) specializes in the research, development, manufacturing, and global distribution of rechargeable lithium-ion and lithium-ion polymer batteries. The company's market reach encompasses Taiwan, the broader Asian region,...
SYNergy ScienTech Corp. Financial Statement Overview
Summary
A split profile. The income statement is weak (score 28): six consecutive years of revenue decline to roughly NT$1.07bn, a deepening net loss of about NT$95m (-8.9% margin), and EBITDA margin collapsing to ~0.7% from ~11.8% — clear operating deleverage, partially offset by gross margins stabilizing in the 18-19% range. The balance sheet is the standout strength (score 76): debt slashed from ~NT$819m to ~NT$93m, debt-to-equity of just 0.07x and roughly 80% equity funding, though equity is slowly eroding as losses accumulate and ROE is negative at ~-6.9%. Cash flow is adequate (score 60): operating cash flow of ~NT$113m and a third straight year of positive free cash flow (~NT$37m) that funded deleveraging, but it is driven by depreciation rather than earnings and converts to only ~3% of revenue. Net result: a strong financial cushion supporting a structurally deteriorating operating business.
Income Statement
28NegativeBalance Sheet
76PositiveCash Flow
60Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.04B | 1.07B | 1.16B | 1.20B | 1.15B | 1.69B |
| Gross Profit | 151.67M | 200.78M | 217.85M | 167.36M | 108.62M | 276.57M |
| EBITDA | -20.19M | 7.49M | 136.86M | 73.55M | 28.07M | 115.47M |
| Net Income | -114.18M | -95.45M | 9.57M | -44.67M | -60.97M | 3.28M |
Balance Sheet | ||||||
| Total Assets | 1.88B | 1.73B | 1.86B | 2.16B | 2.19B | 2.76B |
| Cash, Cash Equivalents and Short-Term Investments | 508.50M | 452.19M | 424.24M | 760.27M | 636.76M | 1.06B |
| Total Debt | 165.26M | 93.47M | 71.75M | 424.32M | 433.95M | 818.52M |
| Total Liabilities | 553.11M | 356.28M | 350.33M | 686.70M | 663.95M | 1.19B |
| Stockholders Equity | 1.33B | 1.38B | 1.51B | 1.47B | 1.52B | 1.57B |
Cash Flow | ||||||
| Free Cash Flow | -51.71M | 36.61M | 40.52M | 173.66M | -24.09M | -63.65M |
| Operating Cash Flow | 38.27M | 113.21M | 94.29M | 230.37M | 53.67M | 49.28M |
| Investing Cash Flow | -121.89M | -44.27M | -78.05M | -58.03M | -77.35M | -112.21M |
| Financing Cash Flow | 38.13M | -10.37M | -375.06M | -58.35M | -416.79M | 435.47M |
SYNergy ScienTech Corp. Peers Comparison
Overall Rating
TW:689970Outperform
TW:696763Neutral
TW:655847Neutral
TW:243438Underperform
TW:640534Underperform
TW:817127Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 70Outperform | TWD 2.05B | 12.78 | ― | 5.80% | 1.56% | 9.82% | |
| 63Neutral | TWD 1.93B | 12.11 | ― | 5.50% | 22.39% | 53.47% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 47Neutral | TWD 1.81B | -16.02 | ― | 1.55% | -10.07% | -349.71% | |
| 38Underperform | TWD 1.71B | -96.35 | ― | ― | 8.72% | -411.56% | |
| 34Underperform | TWD 2.13B | -149.77 | ― | 0.31% | -98.80% | 84.08% | |
| 27Underperform | TWD 2.04B | -8.87 | ― | ― | -21.44% | 63.14% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:6558 | SYNergy ScienTech Corp. | 19.40 | -19.85 | -50.57% | |
| TW:2434 | Mospec Semiconductor Corp. | 46.25 | 15.90 | 52.39% | |
| TW:6405 | Onano Industrial Corp. | 32.35 | 5.20 | 19.15% | |
| TW:6899 | Apex Material Technology Corp. | 48.30 | -2.63 | -5.16% | |
| TW:6967 | Trans-Sun Materials Technology Co., Ltd. | 64.60 | 8.24 | 14.62% | |
| TW:8171 | Formosa Electronic Industries Inc. | 18.25 | -7.15 | -28.15% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
